Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
ANTI-INTERLEUKIN-12 THERAPY PROTECTS MICE IN...
Journal article

ANTI-INTERLEUKIN-12 THERAPY PROTECTS MICE IN LETHAL ENDOTOXEMIA BUT IMPAIRS BACTERIAL CLEARANCE IN MURINE ESCHERICHIA COLI PERITONEAL SEPSIS

Abstract

The overzealous production of proinflammatory cytokines in sepsis can result in shock, multiorgan dysfunction, and even death. In this study we assessed the role of endogenously produced interleukin (IL)-12 in murine models of endotoxemia and Gram-negative peritoneal sepsis. Initial studies indicated that intraperitoneal lipopolysaccharide (LPS) administration to mice induced a significant time-dependent increase in plasma, lung, and liver …

Authors

Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ

Journal

Shock, Vol. 8, No. 5, pp. 349–356

Publisher

Wolters Kluwer

Publication Date

11 1997

DOI

10.1097/00024382-199711000-00006

ISSN

1073-2322